123 related articles for article (PubMed ID: 10813047)
1. Lack of volunteers for vaccine.
AIDS Patient Care STDS; 1999 Sep; 13(9):572. PubMed ID: 10813047
[No Abstract] [Full Text] [Related]
2. Strategies for addressing the social and behavioral challenges of prophylactic HIV vaccine trials.
Chesney MA; Lurie P; Coates TJ
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 May; 9(1):30-5. PubMed ID: 7712232
[No Abstract] [Full Text] [Related]
3. Social and behavioral issues in phase III HIV preventive vaccine trials.
Grinstead OA
AIDS; 1995; 9 Suppl A():S245-50. PubMed ID: 8819592
[No Abstract] [Full Text] [Related]
4. Vaccine trial in Thailand.
AIDS Patient Care STDS; 1999 Jun; 13(6):377. PubMed ID: 10842863
[No Abstract] [Full Text] [Related]
5. Behavioral research contributions to planning and conducting HIV vaccine efficacy studies.
Temoshok LR
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S277-80. PubMed ID: 7865318
[No Abstract] [Full Text] [Related]
6. More women and adolescents needed in HIV vaccine trials.
Expert Rev Vaccines; 2004 Oct; 3(5):501-7. PubMed ID: 15485328
[No Abstract] [Full Text] [Related]
7. AIDS vaccine test to be expanded based on upbeat results.
AIDS Read; 2005 Nov; 15(11):561, 573. PubMed ID: 16329176
[No Abstract] [Full Text] [Related]
8. Vaccine study is enrolling.
AIDS Patient Care STDS; 2005 Apr; 19(4):276-7. PubMed ID: 15920787
[No Abstract] [Full Text] [Related]
9. HIV vaccine trials: critical issues in informed consent.
Lindegger G; Richter LM
S Afr J Sci; 2000 Jun; 96():313-7. PubMed ID: 15739286
[TBL] [Abstract][Full Text] [Related]
10. Vaccine liability and participant compensation incentives in HIV vaccine trials.
Stein RE
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S297-300. PubMed ID: 7865323
[No Abstract] [Full Text] [Related]
11. Volunteers sought for NIH AIDS vaccine study.
AIDS Read; 2005 Nov; 15(11):574. PubMed ID: 16329177
[No Abstract] [Full Text] [Related]
12. Two preventive AIDS vaccine trials begin.
IAVI Rep; 2006; 10(3):19. PubMed ID: 20213981
[No Abstract] [Full Text] [Related]
13. Fifty volunteer for live-vaccine trial.
James JS
AIDS Treat News; 1997 Oct; (No 280):1-2. PubMed ID: 11364735
[TBL] [Abstract][Full Text] [Related]
14. Why we don't need a relative risk standard for adolescent HIV vaccine trials in South Africa.
Slack CM
Am J Bioeth; 2011 Jun; 11(6):21-2. PubMed ID: 21678209
[No Abstract] [Full Text] [Related]
15. Two new AIDS vaccine trials initiated in Africa.
Kresge KJ
IAVI Rep; 2006; 10(6):15. PubMed ID: 20213985
[No Abstract] [Full Text] [Related]
16. Response to Open Peer Commentaries on "Relative versus absolute standards for everyday risk in adolescent HIV prevention trials: expanding the debate".
Snyder J; Miller CL; Gray G
Am J Bioeth; 2011 Jun; 11(6):W1-3. PubMed ID: 21678202
[No Abstract] [Full Text] [Related]
17. Pharmexa-Epimmune and Bavarian Nordic begin AIDS vaccine trial.
IAVI Rep; 2007; 11(2):15. PubMed ID: 20210117
[No Abstract] [Full Text] [Related]
18. HIV vaccine best hope for controlling AIDS, says NNIH.
AIDS Policy Law; 2002 Jun; 17(11):2. PubMed ID: 12083036
[No Abstract] [Full Text] [Related]
19. New oral DNA vaccine funded for trials.
James JS
AIDS Treat News; 2000 Jun; (344):3. PubMed ID: 12170972
[TBL] [Abstract][Full Text] [Related]
20. Here's my arm. My personal experience participating in an HIV-vaccine trial.
Abitol G
Body Posit; 2004; 17(4):22-3. PubMed ID: 15929211
[No Abstract] [Full Text] [Related]
[Next] [New Search]
